Steris Plc Form 8-K Summary
Business Context and Reporting Period
Steris Plc, a company incorporated in Ireland, filed this Current Report on Form 8-K on November 7, 2023. The filing announces financial results for the fiscal 2024 second quarter ended September 30, 2023. The company's ordinary shares and senior notes are registered on the New York Stock Exchange.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1), which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It serves as a notification that the results for the quarter ending September 30, 2023, have been issued.
Guidance, Outlook, and Risks
The filing does not contain management commentary, guidance, outlook, or specific risk factors within the body of the 8-K. The information is furnished pursuant to Item 2.02 and is explicitly stated not to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference into other registration statements.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, earnings, and cash flow figures for the quarter ended September 30, 2023.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any updated forward-looking guidance or commentary on market conditions in the press release.
- Confirm the status of the company's debt obligations (2.700% Senior Notes due 2031 and 3.750% Senior Notes due 2051) in the full financial statements.